Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer's disease.
暂无分享,去创建一个
Jungwon Yoon | Yeongil Noh | A. K. Hoshiar | T. Do | Jungwon Yoon | Faiz Ul Amin | Ali Kafash Hoshiar | Ton Duc Do | Shahid Ali Shah | Muhammad Sohail Khan | Myeong Ok Kim | S. Shah | F. Amin | Muhammad Sohail Khan | Myeong-Ok Kim | Ali Kafash Hoshiar | Yeongil Noh
[1] G. Rosania,et al. Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers. , 2013, ACS nano.
[2] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[3] Carl K. Hoh,et al. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .
[4] B. Liang,et al. Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease* , 2010, The Journal of Biological Chemistry.
[5] P Wust,et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[6] Eva Yuhua Kuo,et al. Increase in Evans blue dye extravasation into the brain in the late developmental stage , 2012, Neuroreport.
[7] P. Hasegawa,et al. Antifungal activity of tobacco osmotin has specificity and involves plasma membrane permeabilization , 1996 .
[8] D. Selkoe. The molecular pathology of Alzheimer's disease , 1991, Neuron.
[9] Lei Han,et al. Construction of Novel Brain-Targeting Gene Delivery System by Natural Magnetic Nanoparticles , 2011 .
[10] R Weissleder,et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.
[11] Brian P. Grady,et al. Magnetic Assisted Transport of PLGA Nanoparticles Through a Human Round Window Membrane Model , 2010 .
[12] E. Landau,et al. Synaptic Stimulation of mTOR Is Mediated by Wnt Signaling and Regulation of Glycogen Synthetase Kinase-3 , 2011, The Journal of Neuroscience.
[13] E. Tiffany-Castiglioni,et al. Evaluation of neurotoxic potential by use of in vitro systems , 2005, Expert opinion on drug metabolism & toxicology.
[14] L. Buée,et al. P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.
[15] M. Kim,et al. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus , 2015, Scientific Reports.
[16] W. Bentley,et al. Towards oriented assembly of proteins onto magnetic nanoparticles , 2008 .
[17] Roy S Herbst,et al. Targeted drug delivery strategies to treat lung metastasis , 2009, Expert opinion on drug delivery.
[18] P. Hasegawa,et al. Characterization of osmotin : a thaumatin-like protein associated with osmotic adaptation in plant cells. , 1987, Plant physiology.
[19] A. Saria,et al. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues , 1983, Journal of Neuroscience Methods.
[20] D. Leslie-Pelecky,et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. , 2005, Molecular pharmaceutics.
[21] Ton Duc Do,et al. Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator. , 2016, Journal of biomedical nanotechnology.
[22] Larry R Squire,et al. Spatial memory, recognition memory, and the hippocampus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Squire. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. , 1992, Psychological review.
[24] A. S. Moses,et al. Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.
[25] Sungho Jin,et al. Magnetic targeting of nanoparticles across the intact blood-brain barrier. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[26] H. Y. Lee,et al. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain , 2014, Cell Death and Disease.
[27] J. Kopeček. Polymer-drug conjugates: origins, progress to date and future directions. , 2013, Advanced drug delivery reviews.
[28] Andras Lakatos,et al. Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS , 2004, The Journal of Neuroscience.
[29] S. Lipton,et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease , 2014, Molecular Neurodegeneration.
[30] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Nair,et al. Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier , 2010, International journal of nanomedicine.
[32] T. Nagai,et al. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. , 2008, Journal of biomedical materials research. Part A.
[33] M A Vandelli,et al. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[34] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[35] T. Nabeshima,et al. β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex , 2004, Behavioural Brain Research.
[36] Walter H Backes,et al. Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. , 2016, Radiology.
[37] B. Cornelissen,et al. A tobacco mosaic virus-induced tobacco protein is homologous to the sweet-tasting protein thaumatin , 1986, Nature.
[38] R. Cunha,et al. Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway , 2009, The Journal of Neuroscience.
[39] H. Y. Lee,et al. Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain , 2014, Cell Death and Disease.
[40] P. Wong,et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.
[41] T. M. Sutherland,et al. Increased permeability of the capillaries of the rat heart to the plasma albumin with asphyxiation and with perfusion , 1966, The Journal of physiology.
[42] Dormer Kenneth,et al. Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field , 2005 .
[43] S. Hébert,et al. Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors , 2012, Scientific Reports.
[44] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[45] M. Moore,et al. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? , 2006, Environment international.
[46] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[47] Yuan Yuan Zhang,et al. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field , 2006, Journal of nanobiotechnology.
[48] Tae-Jong Yoon,et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[49] M. Tabaton,et al. Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway. , 2011, Journal of Alzheimer's disease : JAD.
[50] R. Weissleder,et al. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. , 1990, Radiology.
[51] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[52] W. Statton,et al. Structure in Vitreous Silicate Fibers as Shown by Small‐Angle Scattering of X‐Rays , 1960 .
[53] L. Hersh,et al. Substrate Activation of Insulin-degrading Enzyme (Insulysin) , 2003, Journal of Biological Chemistry.
[54] G. Cole,et al. Why Pleiotropic Interventions are Needed for Alzheimer's Disease , 2010, Molecular Neurobiology.
[55] O. Steinwall,et al. SELECTIVE VULNERABILITY OF THE BLOOD‐BRAIN BARRIER IN CHEMICALLY INDUCED LESIONS , 1966, Journal of neuropathology and experimental neurology.
[57] K Mosbach,et al. Preparation and application of magnetic polymers for targeting of drugs , 1979, FEBS letters.
[58] H M Evans,et al. THE ACTION OF VITAL STAINS BELONGING TO THE BENZIDINE GROUP. , 1914, Science.
[59] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[60] T. Yoshino,et al. Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] Catherine C. Berry,et al. Functionalisation of magnetic nanoparticles for applications in biomedicine , 2003 .
[62] M. Ohno,et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice , 2007, Neurobiology of Disease.
[63] P. Sykes,et al. Cellular transfer and AFM imaging of cancer cells using Bioimprint , 2006, Journal of nanobiotechnology.
[64] D. Woodruff-Pak,et al. Animal models of Alzheimer's disease: therapeutic implications. , 2008, Journal of Alzheimer's disease : JAD.
[65] Jungwon Yoon,et al. A Novel Electromagnetic Actuation System for Magnetic Nanoparticle Guidance in Blood Vessels , 2014, IEEE Transactions on Magnetics.
[66] Scott E McNeil,et al. Nanotechnology safety concerns revisited. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[67] Vladimir P Torchilin,et al. Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.
[68] Huan Xu,et al. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. , 2013, ACS nano.
[69] Mohsin Shah,et al. Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. , 2010, International journal of pharmaceutics.
[70] A. Arrott,et al. Magnetism in Medicine , 1960 .
[71] M. Gregersen,et al. THE DISAPPEARANCE OF T-1824 AND STRUCTURALLY RELATED DYES FROM THE BLOOD STREAM , 1943 .
[72] Jungwon Yoon,et al. A Novel Scheme for Nanoparticle Steering in Blood Vessels Using a Functionalized Magnetic Field , 2015, IEEE Transactions on Biomedical Engineering.
[73] Robert N Grass,et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.
[74] E. Neuwelt,et al. Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor , 2005, Neurosurgery.
[75] G. Hass,et al. VITAL STAINING, SERUM ALBUMIN AND THE BLOOD‐BRAIN BARRIER , 1970, Journal of neuropathology and experimental neurology.
[76] D. Butterfield,et al. Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis , 2009, Acta Neuropathologica.
[77] Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity , 2012, PloS one.
[78] Miqin Zhang,et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.
[79] A. Curtis,et al. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.